MDPB-R SWOT analysis 25/04/2012ARMB-KAGB17 S TRENGHTS WELL-INTEGRATED NETWORK between partners ( DC, CBB,TC, Col.C, HLA lab) Connected to REGISTRIES WORLDWIDE ACTIVE participation with INTERNATIONAL GROUPS (WMDA, Netcord) W EAKNESSES SIZE (international context) LOW INSTITUTIONAL support MOST DONORS ARE FROM ABROAD (for transplantations of Belgian Patients) Potential solutions reachable Cancer plan Official mandate to operate O PPORTUNITIES ACCREDITATION Investment in NEW DATA EXCHANGE TOOLS INCREASE INTERNATIONAL COOPERATION NEW RECRUITMENT STRATEGIES (fe minorities) CONTINUOUS RECRUITMENT ACTION T HREATS AGE/ HLA TYPING level of donor population BIGGER transnational structures with ample funding MORE BELGIAN STEM CELL DONORS (for Belgian-international Patients)
{}